Healthcare entity

MPCi

Company

Every one of those 1 sits in a single category, funding. Aureka Biotechnologies is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. MPCi appears in 1 tracked Healthcare story from August 11, 2026. The tracked stories average 2 original sources each.

Last mentioned: Aug 11, 2026

Entity pulse

Recent coverage · MPCi

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about MPCi

Every one of those 1 sits in a single category, funding. Aureka Biotechnologies is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. MPCi appears in 1 tracked Healthcare story from August 11, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering MPCi. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Series B financing closed

    US$100 million Series B round closed, led by Granite Asia and a strategic investor, bringing total funding to nearly $200 million.

  2. Company founded

    Aureka Biotechnologies is founded as an AI-native TechBio company aiming to build biological world models.

Stories mentioning MPCi 1

Funding Positive

Aureka Biotech Lands $100M Series B to Build AI-Powered Biological World Model

Aureka Biotechnologies raised $100M to advance its foundational AI models that could transform drug discovery from a trial-and-error process into a predictive science. The funding will enhance a closed-loop system integrating AI models with high-throughput lab experiments, potentially slashing the time and cost of bringing new therapies to market.

2 sources

MPCi is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.